Glucose dysregulation with elevated glucose levels and decreased expression of glucose transporters and enzymes in the glycolytic pathway have been observed in AD patients’ brains [38], and impairment or resistance to INS/IGF-1 signaling has long been associated with aging and the development of LOAD [8, 32]. Here, IGF1 is linked to Alzheimer disease.